AP NEWS

DionyMed Brands Appoints Consumer Brand Development Expert, Michelle Sitton, as Chief Marketing Officer

January 15, 2019

TORONTO--(BUSINESS WIRE)--Jan 15, 2019--DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE: DYME), a multi-state vertically integrated cannabis brand and delivery platform, today announced it has appointed Michelle Sitton as the Company’s new Chief Marketing Officer (“CMO”), effective immediately.

Ms. Sitton joins DionyMed leveraging over 20 years of strategic marketing and brand development experience for cannabis and natural products. In her role as CMO, Ms. Sitton will lead DionyMed’s brand-building, product development and go-to market strategy. Her extensive industry experience within the cannabis and natural foods industries will be instrumental as the Company further expands its cannabis brand portfolio and enhances its market position.

“Michelle brings over 20 years of consumer brand experience at top tier CPG companies, like Nestlé, and cannabis companies, like Curaleaf, Inc., to the DYME Brands team,” said Edward Fields, Chief Executive Officer of DionyMed. “Her understanding of the cannabis and natural food industries coupled with her outstanding track record makes her uniquely qualified to help bring DYME’s brands to life. Given her previous success developing several award-winning cannabis brands at Curaleaf, Michelle is undoubtedly the right Chief Marketing Officer to support our rapidly growing portfolio of brands.”

Most recently, Ms. Sitton served as the Acting Head of Brand and Marketing at Curaleaf, Inc., a leading vertically integrated cannabis operator in the United States, where she created five cannabis brands from strategy through launch. Prior to Curaleaf, she served as Innovation and Product Development Team Leader at Navitas Organics, leading new product development and Sales/Marketing process improvement projects. She also spent several years in brand management at Nestlè US, winning a Global Innovation award for her work at PowerBar. She has also held several marketing strategist positions for startups, served as Director of Marketing for several food brands, and has worked with multiple clients in the food/wine and social impact industry in her role as Founder and CEO of Blue Parrot Marketing.

“I am excited to join the DionyMed team at this watershed moment in the history of the cannabis industry,” Ms. Sitton commented. “The Company brings an exciting new approach to the industry, with the potential for significant growth in the short- and long-term. DionyMed’s leadership team has demonstrated, not only a keen understanding of the industry, but a business model that will be able to quickly adapt to the fast-moving pace of the industry at large. I look forward to working with the team to take DionyMed Brands to the next level.”

To be added to the DionyMed e-mail distribution list, please e-mail DionyMed@kcsa.com with DionyMed in the subject line.

About DionyMed

Founded in 2017, DionyMed is a multi-state cannabis brands and distribution platform, supporting cultivators, manufacturers and award-winning brands in the medical and adult-use cannabis markets. DionyMed sells branded products in every category from flower to vape cartridges, concentrates and edibles. DionyMed serves more than 700 dispensaries and completes over 40,000 Direct-To-Consumer deliveries each month with its growing portfolio of products and brands. Learn more at  www.DionyMed.com  and follow @DYME_Inc on  Twitter  and  LinkedIn.

Forward-Looking Information and Statements

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved” and include, without limitation, statements related to the implementation or impact of certain regulations, the expansion of the Company’s online platforms, enhancing the Company’s distribution reach and product variety and changes to the Company’s revenue drivers.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190115005224/en/

CONTACT: Edward Fields, CEO

edward@dionymed.com

408-656-4209Peter Kampian, CFO

pkampian@dionymed.com

416-209-5982Investors:

Phil Carlson / Erika Kay

KCSA Strategic Communications

Phone: 212-896-1233

Email:pcarlson@kcsa.com/ekay@kcsa.comMedia:

Kate Tumino / Tony Forde

KCSA Strategic Communications

212-896-1252 / 347-487-6218

ktumino@kcsa.com/tforde@kcsa.com

KEYWORD: NORTH AMERICA CANADA

INDUSTRY KEYWORD: HEALTH ALTERNATIVE MEDICINE MEDICAL DEVICES MEDICAL SUPPLIES GENERAL HEALTH

SOURCE: DionyMed Brands Inc.

Copyright Business Wire 2019.

PUB: 01/15/2019 08:30 AM/DISC: 01/15/2019 08:30 AM

http://www.businesswire.com/news/home/20190115005224/en

AP RADIO
Update hourly